Ryan M. Thomas

CEO of @Eyamhealth

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

MMV and @EyamHealth are partnering to develop next-gen monoclonal antibody-based #malaria therapies.

The goal? Harnessing advanced biologics and AI to deliver a long-lasting malaria prevention shot that could cost less than $1 per dose. Press release: https://t.co/kExIVLnslc

[Eyam Health @EyamHealth]

Big news in the fight against drug-resistant #malaria:
 Eyam Health and @MedsforMalaria are co-developing a long-acting, AI-designed prevention shot—powered by Gemini—for <$1/dose.

https://t.co/FOLOqlOgNb

@RyanM_Thomas

[Ryan M. Thomas @RyanM_Thomas]

Just checked in at #BiotechShowcase and you can feel the energy and excitement of a return to in-person conferences! https://t.co/ypNOhw6pTb

[Ryan M. Thomas @RyanM_Thomas]

@demy_sara Happy to be back to in-person conferences! Thanks for all of your work in making this happen!

[Ryan M. Thomas @RyanM_Thomas]

Yesterday, @EyamHealth's Chief Scientific Officer, Dr. Jefferies, became the first Canadian immunologist to be inducted in the @AcadofInventors .

He was recognized for his inventions in the field of biomedical research.

#NAIFellow #NAI2022

https://t.co/9VEf8dtyUh

[Eyam Health @EyamHealth]

A universal mRNA vaccine is needed in order to reduce the rate of COVID-19 infection globally. At Eyam, we are devising a safe and effective vaccine to work against all variants of concern. Learn more at https://t.co/dA0qtUINfE.

https://t.co/Lt9YjMtJaz

#universalvaccine

[Eyam Health @EyamHealth]

Eyam's #weeklynews update

Alzheimer's-like changes found in COVID patients' brains: https://t.co/iGIFdSOF2P

Brief incubation, high viral shedding: COVID-19 human challenge trial results: https://t.co/jaKuXZJaPc

Sign-up to our Daily News blast for more: https://t.co/ffyzryEzj6

[Ryan M. Thomas @RyanM_Thomas]

In this month's blog, I look at the need for a pan-coronavirus vaccine because COVID-19 isn't going away anytime soon. Why? Animal reservoirs for COVID-19 variants. https://t.co/KsP5ZOXTLR

[Ryan M. Thomas @RyanM_Thomas]

Real world data coming back supporting our hypothesis - first generation vaccines will need a booster by the Fall #DeltaVariant #COVIDVaccines #booster https://t.co/KXSiDBXbR3

[Ryan M. Thomas @RyanM_Thomas]

Recently, public officials have claimed that the unvaccinated are "variant factories." I'm sharing research that warns against the dangers of imperfect vaccines. This is relevant to the ongoing discussion about how to end the Pandemic. https://t.co/NVXeFLJpkz #CovidIsNotOver

[Ryan M. Thomas @RyanM_Thomas]

Happy to share this short explainer video about the work we're doing at @EyamHealth:

[Eyam Health @EyamHealth]

At Eyam, our researchers are making rapid progress on safe, efficacious, and low dose next generation vaccines.

#covid19 #CovidVaccine #biotech
https://t.co/KTZxGZofRp

[Ryan M. Thomas @RyanM_Thomas]

Proud to have @EyamHealth mentioned among several other biotech peers in British Columbia.

#Biotechs #COVID19Vaccination #COVID19

[Eyam Health @EyamHealth]

"World-class" biotech sector in B.C. advancing many important vaccines and treatments to combat COVID-19.

#COVID19Vaccination #COVID19

https://t.co/GGbvU9emZw

[Andrés Beltramo Alvarez @sacroprofano]

La Relatio Synodi se va a votar por partes, por párrafos, mientras el Mensaje Final se votó todo entero, explica en cardenal Damasceno